Hawthorn Berry — Research Profile

No. Hawthorn is approved in Germany as adjunctive (add-on) therapy for mild heart failure (NYHA class II) but should not replace prescribed medications like ACE inhibitors, beta-blockers, or diuretics ^[1]. The SPICE trial showed that hawthorn is safe alongside conventional heart failure medications ^[2]. Clinical evidence supports adjunctive use at 300–900 mg WS 1442 daily in this context ^[3]. Always discuss adding hawthorn with your cardiologist, especially if you take digoxin.

Clinical trials typically show measurable improvements in exercise tolerance and symptom scores after 6-8 weeks of daily use. Some patients notice reduced fatigue and improved breathing within 3-4 weeks. Hawthorn is not a fast-acting remedy — it provides gradual, cumulative cardiovascular support and should be taken consistently for at least 8-12 weeks to assess full benefit.

WS 1442 is a specific standardized hawthorn extract (standardized to 18.75% oligomeric procyanidins) manufactured by Schwabe Pharmaceuticals. It has been used in virtually all major clinical trials on hawthorn for heart failure, including the SPICE trial. When choosing a hawthorn supplement, look for WS 1442 or an equivalent extract standardized to OPC content to ensure you are getting the same formulation supported by clinical evidence.

Almost all positive clinical evidence comes from standardized hydroalcoholic leaf-and-flower extracts like WS 1442, not from raw berry, powder, or tea. Although products are marketed as "hawthorn berry," the trials that improved heart-failure symptoms used the standardized extract dosed around 900 mg/day, so a comparably standardized extract is the evidence-backed form.

The strongest evidence is as an add-on therapy for chronic heart failure: a Cochrane meta-analysis of 10 trials (855 patients) found greater maximal workload and exercise tolerance and reduced shortness of breath and fatigue versus placebo. That benefit is not settled, however, since the large SPICE trial (2,681 patients over 24 months) found no reduction in cardiac events, and NCCIH describes the overall heart-failure evidence as conflicting and finds no support for weight loss.

Heart-failure trials used a wide range of 160 to 1,800 mg/day of standardized extract; SPICE used 900 mg/day of WS 1442 and the diabetes blood-pressure trial used 1,200 mg/day. No single standard dose is established for general wellness use, and these figures come from specific standardized extracts studied under medical supervision, not from raw berry.

Trials dosed hawthorn once or, more often, split twice daily (for example, 900 mg/day of WS 1442 divided into two doses), but none directly compared morning versus evening administration, so no optimal time of day has been established. The split dosing used in studies is aimed at maintaining steady blood levels rather than targeting a particular time.

In the Cochrane meta-analysis, adverse events were infrequent, mild, and transient, mainly nausea, dizziness, and cardiac or gastrointestinal complaints. NCCIH additionally lists dizziness, nausea, vomiting, diarrhea, and muscle pain as possible effects.

Because hawthorn can lower blood pressure, it may add to the effect of antihypertensive drugs; the diabetes trial gave 1,200 mg/day alongside a mean of 4.4 hypoglycemic and/or antihypertensive medications and found a diastolic drop with no detectable herb-drug interaction. Caution is warranted with digoxin specifically: hawthorn contains constituents structurally similar to digoxin that may interfere with its action in laboratory studies, and hawthorn exposure has been linked to a falsely elevated digoxin level, although the clinical relevance is unsettled. Anyone taking cardiac or blood-pressure medications should use hawthorn only under medical supervision.

Hawthorn has been studied mainly as an adjunct for people with mild-to-moderate (NYHA class II-III) chronic heart failure already on standard therapy, where it modestly improved symptoms and exercise capacity. It is not a replacement for prescribed heart-failure or blood-pressure treatment, and there is no evidence supporting it for weight loss or for general use in otherwise healthy people.

Hawthorn acts gradually rather than acutely. In heart-failure trials it improved exercise tolerance and reduced breathlessness and fatigue versus placebo, though the Cochrane meta-analysis of 10 trials (855 patients) did not report a consistent onset time. The randomized trial in type 2 diabetics saw a modest diastolic blood-pressure drop only after 16 weeks of daily use, so expect a course of weeks, not days, before any effect appears.

Long-term safety is not well established: NCCIH notes that no studies have tested hawthorn for longer than 16 weeks. The longest safety data come from the 24-month SPICE trial, in which 2,681 heart-failure patients took 900 mg/day of the WS 1442 extract with adverse events comparable to placebo, but that finding is specific to a standardized extract in a medically monitored cardiac population.

No formal upper limit is set. Heart-failure trials used 160 to 1,800 mg/day of standardized extract, and higher intakes have mainly caused dizziness, nausea, and gastrointestinal upset rather than serious toxicity. A more important safety issue is product identity: in January 2024 the FDA found that some hawthorn-type and "tejocote" products were adulterated with toxic yellow oleander, which can cause severe or fatal harm, so verified sourcing matters more than dose.

No supplement-to-supplement interactions are well documented, but because hawthorn can lower blood pressure, stacking it with other blood-pressure-lowering botanicals could produce additive effects. Hawthorn berry is itself used in combination products: the Neo40 trial paired it with nitrate-rich beetroot and raised plasma nitrite and nitrate, though that design cannot isolate hawthorn's own contribution.

The best-studied products are standardized leaf-and-flower extracts such as WS 1442, whose characterized active constituents are flavonoids and oligomeric procyanidins, rather than plain berry powder. No single standardization percentage is established across trials, so favor a product that clearly specifies its extract and standardization. Because the FDA has warned that some 'tejocote'/Mexican-hawthorn products actually contain toxic yellow oleander, which can cause severe or fatal harm, prioritize a reputable brand that confirms Crataegus species identity and third-party testing.